A nationwide Danish study tracking over 7,500 young IBD patients found that those with co-occurring ADHD or autism don't face a higher risk of severe disease in the first year — but the picture changes over time. By the 10-year mark, cumulative severe disease rates were slightly higher in the ADHD/autism group (36.2% vs. 33.7%), and these patients were more likely to need advanced therapies like biologics.

The findings also revealed a surgical concern: among ulcerative colitis patients, those with ADHD or autism were more likely to require colectomy (16.3% vs. 12.4%), with the risk being even higher in those diagnosed after 2010. Interestingly, this group had a lower risk of first-time hospitalization but ended up spending more total days in the hospital and making more annual IBD-related healthcare contacts.

Key Takeaways:

• Patients with IBD + ADHD had a higher risk of severe disease later in their course; autism showed a trend toward higher early risk
• Children under 18 with IBD + ADHD/autism were 30% more likely to need advanced therapies
• UC patients with ADHD/autism had a 60% higher risk of colectomy (among those diagnosed after 2010)
• More total hospital days (700 vs. 505 per 1,000 person-years) despite fewer first-time admissions

Why it matters: Clinicians managing IBD in young patients with ADHD or autism should be aware that these comorbidities may signal a more complex long-term disease trajectory — and that ADHD and autism likely influence IBD outcomes through different mechanisms, warranting tailored monitoring and care strategies.